Where does this product stand?

Pick one and read what every state published about it, in its own words, with the source and the date we read it. Free, and no account.

FederalFDA published safety risks

FDA published an assessment of safety risks for this substance. The nomination to allow it in compounding was withdrawn by the nominators, so it is not on a bulks list and is not under evaluation.

FDA published safety risks
BPC-157 Compounded drugs containing BPC-157 may pose risk for immunogenicity for certain routes of administration and may have complexities with regard to peptide-related impurities and active pharmaceutical ingredient (API) characterization.

FDA, same page, table headed "Bulk drug substances nominated but withdrawn": previously in category 2, withdrawn by the nominators. Open the page it came from

HHS conditions apply if a licensed pharmacy fills the order.

  • 1Restricted
  • 2Conditions apply
  • 5New rule found
  • 6Not fully checked
  • 0Bill pending
  • 36No state restriction
RestrictedBPC-157 in Ohio

This state has published wording that forbids it.

Additionally, peptides such as BPC-157 and other bulk drug substances in category 2 and 3 (see FDA guidance ) cannot be compounded because it violates federal and state law.

OH pharmacy board: Ten Common Prescriber Clinic and Medical Spa Violations, read 2026-11-20. Open the page it came from

We report what each state published and quote it exactly. We do not give legal advice.

Watch this, and every other state

The trial checks your own catalogue against all 50 states and tells you when a source changes, with the same quotes and the same links, kept current.

Start your free 14-day trial

14 days. No card. Your email, a password, and what you sell.

Want this checked on every order your brand ships? Leave your work email and we will get in touch.

What the map does not do

It shows you where things stand right now. It does not tell you when that changes, and it does not check an order at the moment somebody places one.